Sehomig M,Eisenhandt A,Ritz E.The microinflammatory state of uremia[J]. BloodPurif,2000,18(4):327-332.
[1]
Sehomig M,Eisenhandt A,Ritz E.The microinflammatory state of uremia[J]. BloodPurif,2000,18(4):327-332.
[2]
Stenvinkel P,Heimburger O,Paulter F,et al.Strong assoeiation between malnutrition,inflammation and atheroselerosis in chronic renal failure[J].Kidney Int,1999,55(5):1899-911.
[2]
Stenvinkel P,Heimburger O,Paulter F,et al.Strong assoeiation between malnutrition,inflammation and atheroselerosis in chronic renal failure[J].Kidney Int,1999,55(5):1899-911.
[3]
Gerdes N,Sukhova G K,Libby P,et al.Expression of interleukin(IL)-18 and Functional IL-18 receptor on human vascular endothelial cells,smooth muscle cells,and macrophages:implications for atherogenesis[J].J Exp Med, 2002,195(2):245-257.
[3]
Gerdes N,Sukhova G K,Libby P,et al.Expression of interleukin(IL)-18 and Functional IL-18 receptor on human vascular endothelial cells,smooth muscle cells,and macrophages:implications for atherogenesis[J].J Exp Med, 2002,195(2):245-257.
[4]
Panieh I V,Miglior M,De Pietro S,et al.The link of biocompatibility to cytokine Production[J].Kidney Int Supple,2000,76:596-603.
[4]
Panieh I V,Miglior M,De Pietro S,et al.The link of biocompatibility to cytokine Production[J].Kidney Int Supple,2000,76:596-603.
[5]
Ariei M,Walls J.End-stages renal disease,atherosclerosis,and cardiovascular mortality is C-reactive protein the missing link[J]. Kidney Int,2001,2:407-414.
[5]
Ariei M,Walls J.End-stages renal disease,atherosclerosis,and cardiovascular mortality is C-reactive protein the missing link[J]. Kidney Int,2001,2:407-414.
[6]
George A,Kaysen G A.Role of inflamation and its treatment in ESRD patients [J]. Blood Purif,2000,18:337-342.
[7]
Muntner P,Hamml L,Kusek J W,et al.The Prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease[J]. Ann Intern Med,2004,140:9-17.
[8]
Owen W F,Lowrie E G.C-reactive Protein as an outcome Predietor for maintenance hemodialysis patients[J].Kidney Int,1998,54(2):627-636.
[6]
George A,Kaysen G A.Role of inflamation and its treatment in ESRD patients [J]. Blood Purif,2000,18:337-342.
[9]
Takayama F,Miyazaki T,Aoyama l,et al.Involvement of interleukin-8 in Dialysis related arthritis[J]. Kidney Int,1998,53(4):1007-1013.
Muntner P,Hamml L,Kusek J W,et al.The Prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease[J]. Ann Intern Med,2004,140:9-17.
[11]
Gerdes N,Sukhova G K,Libby P,et al.Expression of interleukin(IL)-18 and functional IL-18 receptor on human vascular endothelial cells,smooth musele cells,and macrophages:implications for atherogenesis[J].J ExP Med,2002,195(2):245-257.
[8]
Owen W F,Lowrie E G.C-reactive Protein as an outcome Predietor for maintenance hemodialysis patients[J].Kidney Int,1998,54(2):627-636.
[9]
Takayama F,Miyazaki T,Aoyama l,et al.Involvement of interleukin-8 in Dialysis related arthritis[J]. Kidney Int,1998,53(4):1007-1013.
Gerdes N,Sukhova G K,Libby P,et al.Expression of interleukin(IL)-18 and functional IL-18 receptor on human vascular endothelial cells,smooth musele cells,and macrophages:implications for atherogenesis[J].J ExP Med,2002,195(2):245-257.
[13]
Ariei M,Walls J. End-stages renal disease,atherosclerosis,and cardiovascular mortality is C-reactive protein the missing link[J]. Kidney Int,2001,2:407-414.
[14]
Kuo H L,Chou C Y,Liu Y L,et al.Reduction of Pro-inflammatory cytokines Through hemodiafiltration[J].Ren Fail,2008,30(8):796-800.
[12]
侯凡凡.对尿毒症的新认识[J].中华肾脏病杂志,2003,19(2):69-70.
[15]
Muntner P,Hamml L,Kusekj W,et al.The Prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease [J]. Ann Intern Med,2004,140:9-17.
[13]
Ariei M,Walls J. End-stages renal disease,atherosclerosis,and cardiovascular mortality is C-reactive protein the missing link[J]. Kidney Int,2001,2:407-414.
[14]
Kuo H L,Chou C Y,Liu Y L,et al.Reduction of Pro-inflammatory cytokines Through hemodiafiltration[J].Ren Fail,2008,30(8):796-800.
[15]
Muntner P,Hamml L,Kusekj W,et al.The Prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease [J]. Ann Intern Med,2004,140:9-17.
Quarles L D, Sherrard D J, Adler S, et al.The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end stage renal disease[J].J Am Soc Nephrol,2003,14(3):575-583.
[18]
Strazecki P,Adamowicz A,Nartowicz E,et al.Parathormon,calicium,phosphorus,and left ventricular structure and function in normotensive hemodialysis patients[J].Ren Fail, 2001, 23(1):115-126.
[19]
Guo Y S, Yuan W J, Wang L,et al.Parathyroid hormone -potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-κB signalling pathways [J]. Nephrol Dial Transplant ,2011,26:839-847.
Quarles L D, Sherrard D J, Adler S, et al.The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end stage renal disease[J].J Am Soc Nephrol,2003,14(3):575-583.
Strazecki P,Adamowicz A,Nartowicz E,et al.Parathormon,calicium,phosphorus,and left ventricular structure and function in normotensive hemodialysis patients[J].Ren Fail, 2001, 23(1):115-126.
[21]
Shuvy M, Abedat S, Beeri R,et al.Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats[J].Cardiovascular Research,2008,79(3):492-499.
[19]
Guo Y S, Yuan W J, Wang L,et al.Parathyroid hormone -potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-κB signalling pathways [J]. Nephrol Dial Transplant ,2011,26:839-847.
Shuvy M, Abedat S, Beeri R,et al.Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats[J].Cardiovascular Research,2008,79(3):492-499.
[23]
Almqvist E G, Bondeson A G , Bondeson L,et al.Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism[J].Scand J Clin Lab Invest, 2011,71(2):139-144.
Almqvist E G, Bondeson A G , Bondeson L,et al.Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism[J].Scand J Clin Lab Invest, 2011,71(2):139-144.
2013, Vol. 24 
